Inhibition of Alanyl Aminopeptidase Induces MAP-Kinase p42/ERK2 in the Human T Cell Line KARPAS-299
- 9 November 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 252 (1) , 5-9
- https://doi.org/10.1006/bbrc.1998.9585
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activationBiochemical Journal, 1996
- Human aminopeptidase N is encoded by 20 exonsMammalian Genome, 1996
- Expression of Aminopeptidase N on Human Choriocarcinoma Cells and Cell Growth Suppression by the Inhibition of Aminopeptidase N ActivityJapanese Journal of Cancer Research, 1994
- Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N‐terminal cytokine sequencesFEBS Letters, 1993
- Inhibitory effect of bestatin on the growth of human lymphocytesImmunopharmacology, 1992
- Bestatin, an aminopeptidase inhibitor with a multi-pharmacological functionBiomedicine & Pharmacotherapy, 1991
- The human aminopeptidase N gene: isolation, chromosome localization, and DNA polymorphism analysisHuman Genetics, 1990
- Inhibitory Effect of Bestatin on the Growth of Human Leukemic CellsActa Oncologica, 1990
- Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N.Journal of Clinical Investigation, 1989
- Activation of DNA metabolism in T-cells by bestatinBiochemical Pharmacology, 1979